항혈소판제를 투여받는 환자의 치과치료
Dental treatment of the patient with antiplatelet agent
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Antiplatelet agent is administered to the patients who have ischemic heart disease, transient cerebral infarction, as well as hypertension, etc. Antiplatelet agent prevents thromboembolism by inhibition of platelet aggregation by various mechanism. Due to that reason, patient who administered antiplatelet agent has bleeding tendency. Surgeon does not want to make a complication by bleeding during and after operation, and want to stop taking antiplatelet agent. However, It is very dangerous for the patient to stop antiplatelet agent. Local bleeding as a complication after operation is considered minor one, whereas thromboembolism is life threatening serious complication. Most dental intervention can be performed without withdrawal of antiplatelet agent. Dental intervention should be limited area, and surgeon should do active bleeding control.
Abstract
Antiplatelet agent is administered to the patients who have ischemic heart disease, transient cerebral infarction, as well as hypertension, etc. Antiplatelet agent prevents thromboembolism by inhibition of platelet aggregation by various mechanism. Due to that reason, patient who administered antiplatelet agent has bleeding tendency. Surgeon does not want to make a complication by bleeding during and after operation, and want to stop taking antiplatelet agent. However, It is very dangerous for the patient to stop antiplatelet agent. Local bleeding as a complication after operation is considered minor one, whereas thromboembolism is life threatening serious complication. Most dental intervention can be performed without withdrawal of antiplatelet agent. Dental intervention should be limited area, and surgeon should do active bleeding control.
참고문헌 (18)
- Ferro A, "Antiplatelet and anticoagulation therapy" (2013), Springer
- Leon MB, "A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting", Stent anticoagulation restenosis study investigators, 339, pp.1665~1671 (1998)
- Ghantous AE, "Aspirin, Plavix, and other antiplaetlet medications. What the oral and maxillofacial surgeon needs to know", Oral Maxillofac Surg Clin N Am, 28, pp.497~ (2016)
- Artang R, "Analysis of 36 reported cases of late thrombosis in drug eluting stents placed in coronary arteries", Am J Cardiol, 99, pp.1039~1043 (2007)
- 오석규, "수술 전후 항혈소판제제의 관리", 대한내과학회지, 85(1), pp.22~28 (2013), 대한내과학회[DOI]
- 이정근, "Dental management of patients on anti-thrombotic agents", 대한구강악안면외과학회지, 44(4), pp.143~150 (2018), 대한구강악안면외과학회
- Dezsi CA, "Management of denatl patients receiving antiplatelet therapy or chronic oral anticoagulation : A review of the latest evidence", Euro J Gen Surg, 23, pp.196~201 (2017)
- Zabojszcz M, "Saefty of dental extractions in patients on dual antiplaetlet therapy-a meta-analysis", Postepy Kardiol Interwencyjnej, 15(1), pp.68~73 (2019)
- Cervino G, "Advances in Antiplatelet Therapy for Dentofacial Surgery Patients : Focus on Past and Present Strategies", Materials(Basel), 12(9), pp.pii: E1524~ (2019)
- Hao Q, "Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis", BMJ, 363, pp.k5108~ (2018)
- Borges JMDM, "Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?", Ther Clin Risk Manag, 14, pp.1887~1895 (2018)
- Cattaneo M, "Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?", J Thormb Haemost, 10, pp.327~336 (2012)
- Chassot PG, "Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction", Br J Anaesth, 99, pp.316~328 (2007)
- Abualsaud AO, "Perioperative management of patients with drug-eluting stents", JACC Cardiovasc Interv, 3, pp.131~142 (2010)
- Eisenberg MJ, "Safety of short term discontinuation of antiplatelet therapy in patients with drug eluting stents", Circulation, 119, pp.1634~1642 (2009)
- "Management of dental patients taking anticoagulants or antiplatelet drugs. Dental Clinical Guidance" (2015)[URL]
- Burger W, "Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risk after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis", J Intern Med, 257, pp.399~414 (2005)
- P ayne DA, "Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action", J Vasc Surg, 35, pp.1204~1209 (2002)